Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Western Blot), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Laboratories) - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Research
2.1.1.1 Key Secondary Sources
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Primary Sources
2.1.2.2 Key Objectives of Primary Research
2.1.2.3 Key Data from Primary Sources
2.1.2.4 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Company Presentations & Primary Interviews
2.2.3 Top-Down Approach
2.3 Data Triangulation
2.4 Market Share Analysis
2.5 Study Assumptions
2.5.1 Market Assumptions
2.5.2 Growth Rate Assumptions
2.6 Research Limitations
2.6.1 Methodology-Related Limitations
2.6.2 Scope-Related Limitations
2.7 Risk Analysis

4.1 Immunoassay Market Overview
4.2 North America: Immunoassay Market, by Product and Country
4.3 Immunoassay Market: Geographical Snapshot
4.4 Immunoassay Market: Regional Mix

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Chronic and Infectious Diseases
5.2.1.1.1 Increased Use of Immunoassays in Oncology
5.2.1.1.2 Rising Use of Immunoassays in Diagnostic Applications
5.2.1.1.3 High Geriatric Population
5.2.1.2 Increased Demand for Blood Donations in Healthcare Systems and Surgical Procedures
5.2.1.3 Growth in Biotechnology & Biopharmaceutical Industries
5.2.1.4 Increasing Adoption of Immunoassay-based Poc and Rapid Testing
5.2.1.5 Supportive Government Regulatory Policies and Initiatives
5.2.1.6 Increased Consumption of Drugs, Alcohol, and Cannabis
5.2.2 Restraints
5.2.2.1 Stringent Requirements for Approval of Immunoassay Instruments and Consumables
5.2.2.2 Technical Hurdles of Immunoassay Kits
5.2.3 Opportunities
5.2.3.1 Increasing Growth Opportunities in Emerging Economies
5.2.3.2 Focus on Importance of Companion Diagnostics
5.2.3.3 Development of Condition-Specific Biomarkers and Tests
5.2.3.4 Integration of Microfluidics in Immunoassays
5.2.3.5 Improving Immunoassay Diagnostic Technologies
5.2.4 Challenges
5.2.4.1 Design Challenges and Low Quality of Antibodies
5.2.4.2 Dearth of Skilled Professionals
5.3 Regulatory Analysis
5.3.1 Regulatory Framework
5.3.1.1 North America
5.3.1.1.1 US
5.3.1.1.2 Canada
5.3.1.2 Europe
5.3.1.2.1 Russia
5.3.1.3 Asia-Pacific
5.3.1.3.1 Japan
5.3.1.3.2 China
5.3.1.3.3 India
5.3.1.3.4 Indonesia
5.3.1.3.5 South Korea
5.3.1.4 Middle East
5.3.1.4.1 Saudi Arabia
5.3.1.5 Latin America
5.3.1.5.1 Mexico
5.3.1.5.2 Brazil
5.3.1.6 Africa
5.3.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 Elisa
5.4.2 Adjacent Technologies
5.4.2.1 Microfluidics and Miniaturized Platforms
5.4.3 Complementary Technologies
5.4.3.1 Lateral Flow Assays
5.5 Trade Analysis
5.5.1 Import Data for HS Code 382200, 2019-2024
5.5.2 Export Data for HS Code 382200, 2019-2024
5.6 Patent Analysis
5.7 Value Chain Analysis
5.8 Supply Chain Analysis
5.9 Ecosystem Analysis
5.9.1 Role in Ecosystem
5.10 Porter's Five Forces Analysis
5.10.1 Intensity of Competitive Rivalry
5.10.2 Bargaining Power of Suppliers
5.10.3 Bargaining Power of Buyers
5.10.4 Threat of Substitutes
5.10.5 Threat of New Entrants
5.11 Key Stakeholders & Buying Criteria
5.11.1 Key Stakeholders in Buying Process
5.11.2 Key Buying Criteria
5.12 Key Conferences & Events, 2025-2026
5.13 Pricing Analysis
5.13.1 Average Selling Price Trend of Immunoassay Products, by Key Player, 2022-2024
5.13.2 Average Selling Price Trend of Immunoassay Anayzers, by Region, 2022-2024
5.13.3 Average Selling Price Trend of Immunoassay Products, by Type, 2022-2024
5.14 Trends/Disruptions Impacting Customers’ Businesses
5.15 Case Study Analysis
5.15.1 Portable Microfluidic Chemiluminescent Immunoassay to be Used for Rapid COVID-19 Immunity Monitoring
5.15.2 Microfluidic-based Immunoassay to Help in Early Cancer Detection
5.15.3 Luminex-based Multiplex Immunoassay to Aid Autoimmune Disease Profiling
5.16 Investment & Funding Scenario
5.17 Impact of AI/Gen AI on Immunoassay Market
5.17.1 Market Potential for Immunoassay Products
5.17.2 Future of AI/Gen AI in Immunoassay Market
5.18 Impact of 2025 US Tariff on Immunoassay Market
5.18.1 Introduction
5.18.2 Key Tariff Rates
5.18.3 Price Impact Analysis
5.18.4 Impact on Country/Region
5.18.4.1 North America
5.18.4.1.1 US
5.18.4.2 Europe
5.18.4.2.1 Germany
5.18.4.2.2 UK and France
5.18.4.3 Asia-Pacific
5.18.4.3.1 China
5.18.4.3.2 Japan
5.18.4.3.3 India
5.18.5 Impact on End-use Industries
5.18.5.1 Hospitals & Clinics
5.18.5.2 Clinical Laboratories
5.18.5.3 Blood Banks
5.18.5.4 Home Care Settings

6.1 Introduction
6.2 Reagents & Kits
6.2.1 Elisa Reagents & Kits
6.2.1.1 Increased Use of High-Throughput Screening in Drug Discovery Programs to Drive Segment
6.2.2 Rapid Test Reagents & Kits
6.2.2.1 High Demand for Preliminary Screening Tests in Remote Areas to Propel Segment Growth
6.2.3 Elispot Reagents & Kits
6.2.3.1 High Sensitivity, Functionality, and Adaptability of Elispot Technology to Aid Segment Growth
6.2.4 Clia Reagents & Kits
6.2.4.1 Better Diagnosis and Higher Specificity to Augment Segment Growth
6.2.5 Ifa Reagents & Kits
6.2.5.1 Better Adaptability in Clinical Diagnostics to Support Segment Growth
6.2.6 Western Blot Reagents & Kits
6.2.6.1 Western Blot Reagents & Kits to be Considered Gold Standard for Infectious Disease Test Result Validation
6.2.7 Other Reagents & Kits
6.3 Analyzers
6.3.1 Immunoassay Analyzers Market, by Type
6.3.1.1 Open-Ended Systems
6.3.1.1.1 Better Flexibility and Wider Availability to Drive Segment Growth
6.3.1.2 Closed-Ended Systems
6.3.1.2.1 Higher Precision and Better Automation to Fuel Segment Growth
6.3.2 Immunoassay Analyzers Market, by Purchase Mode
6.3.2.1 Rental Purchase
6.3.2.1.1 Increased Convenience and Reduced Liability to Boost Segment Growth
6.3.2.2 Outright Purchase
6.3.2.2.1 Inflated Cost of Immunoassay Testing Technologies to Limit Market Growth

7.1 Introduction
7.2 Elisa
7.2.1 Better Sensitivity and Quicker Results to Drive Market
7.3 Clia
7.3.1 Good Specificity, Wide Linear Range, and High Sensitivity to Aid Market Growth
7.4 Ifa
7.4.1 Ifa to Diagnose Antibodies and Analyze Small Biological and Non-Biological Molecules
7.5 Rapid Tests
7.5.1 Faster Results and Ease of Use to Drive Adoption in Point-Of-Care Diagnosis and Emergency Care Settings
7.6 Western Blotting
7.6.1 Ability to Detect and Confirm Antibodies of Retroviruses to Spur Market Growth
7.7 Elispot
7.7.1 High Sensitivity, Specificity, and Versatility to Propel Market Growth
7.8 Other Technologies

8.1 Introduction
8.2 Blood
8.2.1 High Reliability and Increased Need During Surgical Procedures to Aid Market Growth
8.3 Saliva
8.3.1 Advancements in Immunoassay-based Saliva Tests to Augment Market Growth
8.4 Urine
8.4.1 Increasing Use by Law Enforcement Agencies and Rising Prevalence of Kidney Diseases to Favor Market Growth
8.5 Other Specimens

9.1 Introduction
9.2 Infectious Diseases
9.2.1 Rising Prevalence of Chronic Infectious Diseases to Drive Market
9.3 Endocrinology
9.3.1 Rising Incidence of Diabetes to Augment Market Growth
9.4 Cardiology
9.4.1 High Burden of Cardiovascular Diseases to Support Market Growth
9.5 Autoimmune Disorders
9.5.1 High Incidence and Prevalence of Autoimmune Diseases to Augment Market Growth
9.6 Allergy Diagnostics
9.6.1 Growing Prevalence of Allergies to Aid Market Growth
9.7 Oncology
9.7.1 Rising Burden of Cancer and Growing Emphasis on Early Detection to Propel Market Growth
9.8 Bone & Mineral Disorders
9.8.1 Increasing Prevalence of Osteoporosis, Vitamin D Deficiency, and Arthritis to Aid Market Growth
9.9 Drug Monitoring & Testing
9.9.1 Rising Drug Abuse and Increasing Illicit Drug Consumption to Accelerate Market Growth
9.10 Blood Screening
9.10.1 Rising Emphasis on Blood Donations to Favor Market Growth
9.11 Newborn Screening
9.11.1 Technological Advancements and Favorable Government Initiatives to Propel Market Growth
9.12 Other Applications

10.1 Introduction
10.2 Hospitals & Clinics
10.2.1 Growing Patient Population and Rising Testing Volume to Drive Market
10.3 Clinical Laboratories
10.3.1 Increasing Number of Accredited Laboratories to Drive Market
10.4 Home Care Settings
10.4.1 Rising Utilization of Poc Diagnostics and At-Home Antigen Diagnosis to Propel Market Growth
10.5 Blood Banks
10.5.1 Increasing Number of Accidents and Rising Demand for Blood During Surgeries to Spur Market Growth

11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook for North America
11.2.2 US
11.2.2.1 US to Dominate North American Immunoassay Market During Forecast Period
11.2.3 Canada
11.2.3.1 Increasing Government Support and Rising Incidence of Chronic Diseases to Augment Market Growth
11.3 Europe
11.3.1 Macroeconomic Outlook for Europe
11.3.2 Germany
11.3.2.1 High Healthcare Spending and Favorable Government Initiatives to Propel Market Growth
11.3.3 Italy
11.3.3.1 Rising Geriatric Population and Increasing Cancer Prevalence to Spur Market Growth
11.3.4 France
11.3.4.1 Increased Use of Poc Testing and Favorable Reimbursement Policies to Boost Market Growth
11.3.5 Spain
11.3.5.1 Increasing Adoption of Technologically Advanced Immunoassay Systems to Augment Market Growth
11.3.6 UK
11.3.6.1 Government Support for Disease Diagnostics and Favorable Investment Scenario to Drive Market
11.3.7 Russia
11.3.7.1 Increasing Access to Quality Healthcare and Developing Pharmaceutical Industry to Favor Market Growth
11.3.8 Rest of Europe
11.4 Asia-Pacific
11.4.1 Macroeconomic Outlook for Asia-Pacific
11.4.2 Japan
11.4.2.1 Increasing Investments in Healthcare Technologies and Research Activities to Fuel Market Growth
11.4.3 China
11.4.3.1 Increasing Government Investments and Rising Geriatric Population to Accelerate Maket Growth
11.4.4 India
11.4.4.1 Growing Medical Tourism and Improving Healthcare Infrastructure to Propel Market Growth
11.4.5 Australia
11.4.5.1 Increasing Incidence of Cancer and Rising Focus on Blood Donations to Favor Market Growth
11.4.6 South Korea
11.4.6.1 Rising Healthcare Spending and Increasing Research Investments to Fuel Market Growth
11.4.7 Indonesia
11.4.7.1 High Geriatric Population and Favorable Government Healthcare Policies to Accelerate Market Growth
11.4.8 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook for Latin America
11.5.2 Brazil
11.5.2.1 High Incidence of Infectious Diseases and Presence of Academic & Research Institutes to Boost Market Growth
11.5.3 Mexico
11.5.3.1 Increasing Geriatric Population and Rising Popularity of Medical Tourism to Propel Market Growth
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Lack of Skilled Laboratory Personnel and Unfavorable Reimbursement Policies to Limit Market Growth

12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Key Strategies Adopted by Major Players in Immunoassay Market
12.3 Revenue Analysis, 2020-2024
12.4 Market Share Analysis, 2024
12.5 Company Evaluation Matrix: Key Players, 2024
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2024
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Product Footprint
12.5.5.4 Specimen Footprint
12.6 Company Evaluation Matrix: Startups/SMEs, 2024
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/SMEs, 2024
12.6.5.1 List of Key Startups/SMEs
12.6.5.2 Competitive Benchmarking of Key Startups/SMEs
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 Competitive Scenario
12.9.1 Product Launches/Approvals/ Enhancements
12.9.2 Deals

13.1 Key Players
13.1.1 Abbott
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 Analyst's View
13.1.1.4.1 Right to Win
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses & Competitive Threats
13.1.2 F. Hoffmann-La Roche Ltd.
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product Launches and Approvals
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 Analyst's View
13.1.2.4.1 Right to Win
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses & Competitive Threats
13.1.3 Siemens Healthineers AG
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches and Approvals
13.1.3.3.2 Deals
13.1.3.3.3 Expansions
13.1.3.4 Analyst's View
13.1.3.4.1 Right to Win
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses & Competitive Threats
13.1.4 Danaher
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Product Launches and Approvals
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.4 Analyst's View
13.1.4.4.1 Right to Win
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses & Competitive Threats
13.1.5 Thermo Fisher Scientific Inc.
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Product Approvals
13.1.5.3.2 Deals
13.1.5.4 Analyst's View
13.1.5.4.1 Right to Win
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses & Competitive Threats
13.1.6 Revvity
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Approvals
13.1.6.3.2 Other Developments
13.1.7 Becton, Dickinson and Company (Bd)
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Expansions
13.1.8 Diasorin S.P.A.
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Product Launches and Approvals
13.1.8.3.2 Deals
13.1.9 Bio-Rad Laboratories, Inc.
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Launches
13.1.9.3.2 Deals
13.1.10 Quidelortho Corporation
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Product Approvals
13.1.10.3.2 Deals
13.1.10.3.3 Expansions
13.1.11 Biomérieux
13.1.11.1 Business Overview
13.1.11.2 Products Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Product Launches and Approvals
13.1.11.3.2 Deals
13.1.12 Qiagen
13.1.12.1 Business Overview
13.1.12.2 Products Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Deals
13.1.13 Sysmex Corporation
13.1.13.1 Business Overview
13.1.13.2 Products Offered
13.1.13.3 Recent Developments
13.1.13.3.1 Deals
13.1.13.3.2 Expansions
13.1.14 Agilent Technologies, Inc.
13.1.14.1 Business Overview
13.1.14.2 Products Offered
13.1.14.3 Recent Developments
13.1.14.3.1 Product Launches and Approvals
13.1.14.3.2 Deals
13.1.14.3.3 Other Developments
13.1.15 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
13.1.15.1 Business Overview
13.1.15.2 Products Offered
13.2 Other Players
13.2.1 Merck KGaA
13.2.2 Meridian Bioscience
13.2.3 Bio-Techne
13.2.4 Cellabs
13.2.5 Abnova Corporation
13.2.6 J. Mitra & Co. Pvt. Ltd.
13.2.7 Tosoh Corporation (Tosoh Biosciences)
13.2.8 Cell Sciences
13.2.9 Enzo Biochem Inc.
13.2.10 Creative Diagnostics
13.2.11 Boster Biological Technology
13.2.12 Elabscience Bionovaton Inc.
13.2.13 Wak-Chemie Medical GmbH
13.2.14 Sera Care
13.2.15 Epitope Diagnostics, Inc.
13.2.16 Kamiya Biomedical Company
13.2.17 Gyros Protein Technologies Ab
13.2.18 Trivitron Healthcare
13.2.19 Inbios International, Inc.
13.2.20 Maccura Biotechnology Co. Ltd.

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

Table 1 Immunoassay Market: Inclusions & Exclusions
Table 2 Immunoassay Market: Key Data from Primary Sources
Table 3 Immunoassay Market: Market Assumptions
Table 4 Immunoassay Market: Risk Analysis
Table 5 Increasing Incidence of Cancer, by Region, 2020 vs. 2030 vs. 2040 (Million)
Table 6 Projected Number of Cancer Patients, by Cancer Type, 2015 vs. 2018 vs. 2035 (Units)
Table 7 Detection Time of Drug or Drug Class in Urine Testing
Table 8 Estimated Percentage Increase in Geriatric Population, by Region, 2022 vs. 2030 vs. 2050
Table 9 Recent Developments in Immunoassay Market, 2021-2023
Table 10 New Tests Launched by Key Players, 2021-2023
Table 11 Lab-On-Chip Immunoassays/Devices/Systems Offered by Key Players
Table 12 US: Classification and Risk Level of Immunoassay Products
Table 13 Europe: Classification and Risk Level of In-Virto Diagnostic Devices
Table 14 Russia: Classification and Risk Level of In-Virto Diagnostic Devices
Table 15 Japan: Classification of In-Virto Diagnostic Reagents
Table 16 Japan: Time, Cost, and Complexity of Registration Process
Table 17 China: Time, Cost, and Complexity of Registration Process
Table 18 Indonesia: Registration Process for In-Virto Diagnostic Devices
Table 19 South Korea: Time, Cost, and Complexity of Registration Process
Table 20 Saudi Arabia: Time, Cost, and Complexity of Registration Process
Table 21 Mexico: Time, Cost, and Complexity of Registration Process
Table 22 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 23 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 24 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 25 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 26 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 27 Conventional Immunoassay Methods and Techniques
Table 28 Recent Product Launches with Advanced Technologies in Immunoassay Market
Table 29 Import Data for HS Code 382200, by Country, 2019-2024 (USD Million)
Table 30 Export Data for HS Code 382200, by Country, 2019-2024 (USD Million)
Table 31 Immunoassay Market: Role in Ecosystem
Table 32 Immunoassay Market: Porter's Five Forces
Table 33 Influence of Key Stakeholders on Buying Process
Table 34 Key Buying Criteria, by End-user
Table 35 Immunoassay Market: List of Key Conferences & Events, January 2025-December 2026
Table 36 Average Selling Price Trend of Immunoassay Products, by Key Player, 2022-2024 (USD)
Table 37 Average Selling Price Trend of Clinical Immunoassay Analyzers, by Region, 2022-2024 (USD)
Table 38 Average Selling Price Trend of Immunoassay Products, by Type, 2022-2024 (USD)
Table 39 Case Study 1: Portable Microfluidic Chemiluminescent Immunoassay to be Used for Rapid COVID-19 Immunity Monitoring
Table 40 Case Study 2: Microfluidic-based Immunoassay to Help in Early Cancer Detection
Table 41 Case Study 3: Luminex-based Multiplex Immunoassay to Aid Autoimmune Disease Profiling
Table 42 US Adjusted Reciprocal Tariff Rates
Table 43 Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 44 Key Reagents & Kits Available in Market
Table 45 Immunoassay Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 46 Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 47 North America: Immunoassay Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 48 Europe: Immunoassay Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 49 Asia-Pacific: Immunoassay Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 50 Latin America: Immunoassay Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 51 Elisa Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 52 North America: Elisa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 53 Europe: Elisa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 54 Asia-Pacific: Elisa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 55 Latin America: Elisa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 56 Rapid Test Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 57 North America: Rapid Test Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 58 Europe: Rapid Test Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 59 Asia-Pacific: Rapid Test Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 60 Latin America: Rapid Test Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 61 Elispot Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 62 North America: Elispot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 63 Europe: Elispot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 64 Asia-Pacific: Elispot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 65 Latin America: Elispot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 66 Clia Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 67 North America: Clia Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 68 Europe: Clia Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 69 Asia-Pacific: Clia Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 70 Latin America: Clia Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 71 Ifa Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 72 North America: Ifa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 73 Europe: Ifa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 74 Asia-Pacific: Ifa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 75 Latin America: Ifa Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 76 Western Blot Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 77 North America: Western Blot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 78 Europe: Western Blot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 79 Asia-Pacific: Western Blot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 80 Latin America: Western Blot Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 81 Other Reagents & Kits Market, by Region, 2023-2030 (USD Million)
Table 82 North America: Other Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 83 Europe: Other Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 84 Asia-Pacific: Other Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 85 Latin America: Other Reagents & Kits Market, by Country, 2023-2030 (USD Million)
Table 86 Key Analyzers Available in Market
Table 87 Immunoassay Analyzers Market, by Region, 2023-2030 (USD Million)
Table 88 North America: Immunoassay Analyzers Market, by Country, 2023-2030 (USD Million)
Table 89 Europe: Immunoassay Analyzers Market, by Country, 2023-2030 (USD Million)
Table 90 Asia-Pacific: Immunoassay Analyzers Market, by Country, 2023-2030 (USD Million)
Table 91 Latin America: Immunoassay Analyzers Market, by Country, 2023-2030 (USD Million)
Table 92 Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 93 Open-Ended Systems Market, by Region, 2023-2030 (USD Million)
Table 94 North America: Open-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 95 Europe: Open-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 96 Asia-Pacific: Open-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 97 Latin America: Open-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 98 Closed-Ended Systems Market, by Region, 2023-2030 (USD Million)
Table 99 North America: Closed-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 100 Europe: Closed-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 101 Asia-Pacific: Closed-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 102 Latin America: Closed-Ended Systems Market, by Country, 2023-2030 (USD Million)
Table 103 Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 104 Rental Purchase Market, by Region, 2023-2030 (USD Million)
Table 105 North America: Rental Purchase Market, by Country, 2023-2030 (USD Million)
Table 106 Europe: Rental Purchase Market, by Country, 2023-2030 (USD Million)
Table 107 Asia-Pacific: Rental Purchase Market, by Country, 2023-2030 (USD Million)
Table 108 Latin America: Rental Purchase Market, by Country, 2023-2030 (USD Million)
Table 109 Outright Purchase Market, by Region, 2023-2030 (USD Million)
Table 110 North America: Outright Purchase Market, by Country, 2023-2030 (USD Million)
Table 111 Europe: Outright Purchase Market, by Country, 2023-2030 (USD Million)
Table 112 Asia-Pacific: Outright Purchase Market, by Country, 2023-2030 (USD Million)
Table 113 Latin America: Outright Purchase Market, by Country, 2023-2030 (USD Million)
Table 114 Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 115 Immunoassay Technology Market, by Region, 2023-2030 (USD Million)
Table 116 North America: Immunoassay Technology Market, by Country, 2023-2030 (USD Million)
Table 117 Europe: Immunoassay Technology Market, by Country, 2023-2030 (USD Million)
Table 118 Asia-Pacific: Immunoassay Technology Market, by Country, 2023-2030 (USD Million)
Table 119 Latin America: Immunoassay Technology Market, by Country, 2023-2030 (USD Million)
Table 120 Key Elisa Technologies Available in Market
Table 121 Immunoassay Market for Elisa, by Region, 2023-2030 (USD Million)
Table 122 North America: Immunoassay Market for Elisa, by Country, 2023-2030 (USD Million)
Table 123 Europe: Immunoassay Market for Elisa, by Country, 2023-2030 (USD Million)
Table 124 Asia-Pacific: Immunoassay Market Elisa, by Country, 2023-2030 (USD Million)
Table 125 Latin America: Immunoassay Market for Elisa, by Country, 2023-2030 (USD Million)
Table 126 Immunoassay Market for Clia, by Region, 2023-2030 (USD Million)
Table 127 North America: Immunoassay Market for Clia, by Country, 2023-2030 (USD Million)
Table 128 Europe: Immunoassay Market for Clia, by Country, 2023-2030 (USD Million)
Table 129 Asia-Pacific: Immunoassay Market Clia, by Country, 2023-2030 (USD Million)
Table 130 Latin America: Immunoassay Market for Clia, by Country, 2023-2030 (USD Million)
Table 131 Immunoassay Market for Ifa, by Region, 2023-2030 (USD Million)
Table 132 North America: Immunoassay Market for Ifa, by Country, 2023-2030 (USD Million)
Table 133 Europe: Immunoassay Market for Ifa, by Country, 2023-2030 (USD Million)
Table 134 Asia-Pacific: Immunoassay Market Ifa, by Country, 2023-2030 (USD Million)
Table 135 Latin America: Immunoassay Market for Ifa, by Country, 2023-2030 (USD Million)
Table 136 Key Rapid Tests Available in Market
Table 137 Immunoassay Market for Rapid Tests, by Region, 2023-2030 (USD Million)
Table 138 North America: Immunoassay Market for Rapid Tests, by Country, 2023-2030 (USD Million)
Table 139 Europe: Immunoassay Market for Rapid Tests, by Country, 2023-2030 (USD Million)
Table 140 Asia-Pacific: Immunoassay Market Rapid Tests, by Country, 2023-2030 (USD Million)
Table 141 Latin America: Immunoassay Market for Rapid Tests, by Country, 2023-2030 (USD Million)
Table 142 Key Western Blotting Systems Available in Market
Table 143 Immunoassay Market for Western Blotting, by Region, 2023-2030 (USD Million)
Table 144 North America: Immunoassay Market for Western Blotting, by Country, 2023-2030 (USD Million)
Table 145 Europe: Immunoassay Market for Western Blotting, by Country, 2023-2030 (USD Million)
Table 146 Asia-Pacific: Immunoassay Market Western Blotting, by Country, 2023-2030 (USD Million)
Table 147 Latin America: Immunoassay Market for Western Blotting, by Country, 2023-2030 (USD Million)
Table 148 Immunoassay Market for Elispot, by Region, 2023-2030 (USD Million)
Table 149 North America: Immunoassay Market for Elispot, by Country, 2023-2030 (USD Million)
Table 150 Europe: Immunoassay Market for Elispot, by Country, 2023-2030 (USD Million)
Table 151 Asia-Pacific: Immunoassay Market for Elispot, by Country, 2023-2030 (USD Million)
Table 152 Latin America: Immunoassay Market for Elispot, by Country, 2023-2030 (USD Million)
Table 153 Immunoassay Market for Other Technologies, by Region, 2023-2030 (USD Million)
Table 154 North America: Immunoassay Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 155 Europe: Immunoassay Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 156 Asia-Pacific: Immunoassay Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 157 Latin America: Immunoassay Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 158 Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 159 Immunoassay Specimen Market, by Region, 2023-2030 (USD Million)
Table 160 North America: Immunoassay Specimen Market, by Country, 2023-2030 (USD Million)
Table 161 Europe: Immunoassay Specimen Market, by Country, 2023-2030 (USD Million)
Table 162 Asia-Pacific: Immunoassay Specimen Market, by Country, 2023-2030 (USD Million)
Table 163 Latin America: Immunoassay Specimen Market, by Country, 2023-2030 (USD Million)
Table 164 Immunoassay Market for Blood, by Region, 2023-2030 (USD Million)
Table 165 North America: Immunoassay Market for Blood, by Country, 2023-2030 (USD Million)
Table 166 Europe: Immunoassay Market for Blood, by Country, 2023-2030 (USD Million)
Table 167 Asia-Pacific: Immunoassay Market for Blood, by Country, 2023-2030 (USD Million)
Table 168 Latin America: Immunoassay Market for Blood, by Country, 2023-2030 (USD Million)
Table 169 Immunoassay Market for Saliva, by Region, 2023-2030 (USD Million)
Table 170 North America: Immunoassay Market for Saliva, by Country, 2023-2030 (USD Million)
Table 171 Europe: Immunoassay Market for Saliva, by Country, 2023-2030 (USD Million)
Table 172 Asia-Pacific: Immunoassay Market for Saliva, by Country, 2023-2030 (USD Million)
Table 173 Latin America: Immunoassay Market for Saliva, by Country, 2023-2030 (USD Million)
Table 174 Immunoassay Market for Urine, by Region, 2023-2030 (USD Million)
Table 175 North America: Immunoassay Market for Urine, by Country, 2023-2030 (USD Million)
Table 176 Europe: Immunoassay Market for Urine, by Country, 2023-2030 (USD Million)
Table 177 Asia-Pacific: Immunoassay Market for Urine, by Country, 2023-2030 (USD Million)
Table 178 Latin America: Immunoassay Market for Urine, by Country, 2023-2030 (USD Million)
Table 179 Immunoassay Market for Other Specimens, by Region, 2023-2030 (USD Million)
Table 180 North America: Immunoassay Market for Other Specimens, by Country, 2023-2030 (USD Million)
Table 181 Europe: Immunoassay Market for Other Specimens, by Country, 2023-2030 (USD Million)
Table 182 Asia-Pacific: Immunoassay Market for Other Specimens, by Country, 2023-2030 (USD Million)
Table 183 Latin America: Immunoassay Market for Other Specimens, by Country, 2023-2030 (USD Million)
Table 184 Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 185 Immunoassay Application Market, by Region, 2023-2030 (USD Million)
Table 186 North America: Immunoassay Application Market, by Country, 2023-2030 (USD Million)
Table 187 Europe: Immunoassay Application Market, by Country, 2023-2030 (USD Million)
Table 188 Asia-Pacific: Immunoassay Application Market, by Country, 2023-2030 (USD Million)
Table 189 Latin America: Immunoassay Application Market, by Country, 2023-2030 (USD Million)
Table 190 Immunoassay Market for Infectious Diseases, by Region, 2023-2030 (USD Million)
Table 191 North America: Immunoassay Market for Infectious Diseases, by Country, 2023-2030 (USD Million)
Table 192 Europe: Immunoassay Market for Infectious Diseases, by Country, 2023-2030 (USD Million)
Table 193 Asia-Pacific: Immunoassay Market for Infectious Diseases, by Country, 2023-2030 (USD Million)
Table 194 Latin America: Immunoassay Market for Infectious Diseases, by Country, 2023-2030 (USD Million)
Table 195 Immunoassay Market for Endocrinology, by Region, 2023-2030 (USD Million)
Table 196 North America: Immunoassay Market for Endocrinology, by Country, 2023-2030 (USD Million)
Table 197 Europe: Immunoassay Market for Endocrinology, by Country, 2023-2030 (USD Million)
Table 198 Asia-Pacific: Immunoassay Market for Endocrinology, by Country, 2023-2030 (USD Million)
Table 199 Latin America: Immunoassay Market for Endocrinology, by Country, 2023-2030 (USD Million)
Table 200 Key Products Available for Cardiology Applications
Table 201 Immunoassay Market for Cardiology, by Region, 2023-2030 (USD Million)
Table 202 North America: Immunoassay Market for Cardiology, by Country, 2023-2030 (USD Million)
Table 203 Europe: Immunoassay Market for Cardiology, by Country, 2023-2030 (USD Million)
Table 204 Asia-Pacific: Immunoassay Market for Cardiology, by Country, 2023-2030 (USD Million)
Table 205 Latin America: Immunoassay Market for Cardiology, by Country, 2023-2030 (USD Million)
Table 206 Immunoassay Market for Autoimmune Disorders, by Region, 2023-2030 (USD Million)
Table 207 North America: Immunoassay Market for Autoimmune Disorders, by Country, 2023-2030 (USD Million)
Table 208 Europe: Immunoassay Market for Autoimmune Disorders, by Country, 2023-2030 (USD Million)
Table 209 Asia-Pacific: Immunoassay Market for Autoimmune Disorders, by Country, 2023-2030 (USD Million)
Table 210 Latin America: Immunoassay Market for Autoimmune Disorders, by Country, 2023-2030 (USD Million)
Table 211 Immunoassay Market for Allergy Diagnostics, by Region, 2023-2030 (USD Million)
Table 212 North America: Immunoassay Market for Allergy Diagnostics, by Country, 2023-2030 (USD Million)
Table 213 Europe: Immunoassay Market for Allergy Diagnostics, by Country, 2023-2030 (USD Million)
Table 214 Asia-Pacific: Immunoassay Market for Allergy Diagnostics, by Country, 2023-2030 (USD Million)
Table 215 Latin America: Immunoassay Market for Allergy Diagnostics, by Country, 2023-2030 (USD Million)
Table 216 Increasing Incidence of Cancer, by Region, 2021 vs. 2030 vs. 2040 (Million)
Table 217 Immunoassay Market for Oncology, by Region, 2023-2030 (USD Million)
Table 218 North America: Immunoassay Market for Oncology, by Country, 2023-2030 (USD Million)
Table 219 Europe: Immunoassay Market for Oncology, by Country, 2023-2030 (USD Million)
Table 220 Asia-Pacific: Immunoassay Market for Oncology, by Country, 2023-2030 (USD Million)
Table 221 Latin America: Immunoassay Market for Oncology, by Country, 2023-2030 (USD Million)
Table 222 Key Products Available for Bone & Mineral Disorders
Table 223 Immunoassay Market for Bone & Mineral Disorders, by Region, 2023-2030 (USD Million)
Table 224 North America: Immunoassay Market for Bone & Mineral Disorders, by Country, 2023-2030 (USD Million)
Table 225 Europe: Immunoassay Market for Bone & Mineral Disorders, by Country, 2023-2030 (USD Million)
Table 226 Asia-Pacific: Immunoassay Market for Bone & Mineral Disorders, by Country, 2023-2030 (USD Million)
Table 227 Latin America: Immunoassay Market for Bone & Mineral Disorders, by Country, 2023-2030 (USD Million)
Table 228 Key Products Available for Drug Monitoring & Testing
Table 229 Key Immunoassay Products Available for Drug Monitoring & Testing
Table 230 Immunoassay Market for Drug Monitoring & Testing, by Region, 2023-2030 (USD Million)
Table 231 North America: Immunoassay Market for Drug Monitoring & Testing, by Country, 2023-2030 (USD Million)
Table 232 Europe: Immunoassay Market for Drug Monitoring & Testing, by Country, 2023-2030 (USD Million)
Table 233 Asia-Pacific: Immunoassay Market for Drug Monitoring & Testing, by Country, 2023-2030 (USD Million)
Table 234 Latin America: Immunoassay Market for Drug Monitoring & Testing, by Country, 2023-2030 (USD Million)
Table 235 Immunoassay Market for Blood Screening, by Region, 2023-2030 (USD Million)
Table 236 North America: Immunoassay Market for Blood Screening, by Country, 2023-2030 (USD Million)
Table 237 Europe: Immunoassay Market for Blood Screening, by Country, 2023-2030 (USD Million)
Table 238 Asia-Pacific: Immunoassay Market for Blood Screening, by Country, 2023-2030 (USD Million)
Table 239 Latin America: Immunoassay Market for Blood Screening, by Country, 2023-2030 (USD Million)
Table 240 Key Products Available for Newborn Screening
Table 241 Immunoassay Market for Newborn Screening, by Region, 2023-2030 (USD Million)
Table 242 North America: Immunoassay Market for Newborn Screening, by Country, 2023-2030 (USD Million)
Table 243 Europe: Immunoassay Market for Newborn Screening, by Country, 2023-2030 (USD Million)
Table 244 Asia-Pacific: Immunoassay Market for Newborn Screening, by Country, 2023-2030 (USD Million)
Table 245 Latin America: Immunoassay Market for Newborn Screening, by Country, 2023-2030 (USD Million)
Table 246 Immunoassay Market for Other Applications, by Region, 2023-2030 (USD Million)
Table 247 North America: Immunoassay Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 248 Europe: Immunoassay Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 249 Asia-Pacific: Immunoassay Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 250 Latin America: Immunoassay Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 251 Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 252 Immunoassay End-user Market, by Region, 2023-2030 (USD Million)
Table 253 North America: Immunoassay End-user Market, by Country, 2023-2030 (USD Million)
Table 254 Europe: Immunoassay End-user Market, by Country, 2023-2030 (USD Million)
Table 255 Asia-Pacific: Immunoassay End-user Market, by Country, 2023-2030 (USD Million)
Table 256 Latin America: Immunoassay End-user Market, by Country, 2023-2030 (USD Million)
Table 257 Immunoassay Market for Hospitals & Clinics, by Region, 2023-2030 (USD Million)
Table 258 North America: Immunoassay Market for Hospitals & Clinics, by Country, 2023-2030 (USD Million)
Table 259 Europe: Immunoassay Market for Hospitals & Clinics, by Country, 2023-2030 (USD Million)
Table 260 Asia-Pacific: Immunoassay Market for Hospitals & Clinics, by Country, 2023-2030 (USD Million)
Table 261 Latin America: Immunoassay Market for Hospitals & Clinics, by Country, 2023-2030 (USD Million)
Table 262 Immunoassay Market for Clinical Laboratories, by Region, 2023-2030 (USD Million)
Table 263 North America: Immunoassay Market for Clinical Laboratories, by Country, 2023-2030 (USD Million)
Table 264 Europe: Immunoassay Market for Clinical Laboratories, by Country, 2023-2030 (USD Million)
Table 265 Asia-Pacific: Immunoassay Market for Clinical Laboratories, by Country, 2023-2030 (USD Million)
Table 266 Latin America: Immunoassay Market for Clinical Laboratories, by Country, 2023-2030 (USD Million)
Table 267 Immunoassay Market for Home Care Settings, by Region, 2023-2030 (USD Million)
Table 268 North America: Immunoassay Market for Home Care Settings, by Country, 2023-2030 (USD Million)
Table 269 Europe: Immunoassay Market for Home Care Settings, by Country, 2023-2030 (USD Million)
Table 270 Asia-Pacific: Immunoassay Market for Home Care Settings, by Country, 2023-2030 (USD Million)
Table 271 Latin America: Immunoassay Market for Home Care Settings, by Country, 2023-2030 (USD Million)
Table 272 Immunoassay Market for Blood Banks, by Region, 2023-2030 (USD Million)
Table 273 North America: Immunoassay Market for Blood Banks, by Country, 2023-2030 (USD Million)
Table 274 Europe: Immunoassay Market for Blood Banks, by Country, 2023-2030 (USD Million)
Table 275 Asia-Pacific: Immunoassay Market for Blood Banks, by Country, 2023-2030 (USD Million)
Table 276 Latin America: Immunoassay Market for Blood Banks, by Country, 2023-2030 (USD Million)
Table 277 Immunoassay Market, by Region, 2023-2030 (USD Million)
Table 278 North America: Key Macroindicators
Table 279 North America: Immunoassay Market, by Country, 2023-2030 (USD Million)
Table 280 North America: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 281 North America: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 282 North America: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 283 North America: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 284 North America: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 285 North America: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 286 North America: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 287 North America: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 288 US: Number of in Vitro Diagnostics Tests Conducted, 2022-2030 (Billion Units)
Table 289 US: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 290 US: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 291 US: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 292 US: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 293 US: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 294 US: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 295 US: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 296 US: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 297 Canada: Estimated Prevalence of Diabetes, 2024 vs. 2034
Table 298 Canada: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 299 Canada: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 300 Canada: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 301 Canada: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 302 Canada: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 303 Canada: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 304 Canada: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 305 Canada: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 306 Europe: Key Macroindicators
Table 307 Europe: Immunoassay Market, by Country, 2023-2030 (USD Million)
Table 308 Europe: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 309 Europe: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 310 Europe: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 311 Europe: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 312 Europe: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 313 Europe: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 314 Europe: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 315 Europe: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 316 Germany: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 317 Germany: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 318 Germany: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 319 Germany: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 320 Germany: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 321 Germany: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 322 Germany: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 323 Germany: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 324 Italy: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 325 Italy: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 326 Italy: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 327 Italy: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 328 Italy: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 329 Italy: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 330 Italy: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 331 Italy: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 332 France: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 333 France: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 334 France: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 335 France: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 336 France: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 337 France: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 338 France: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 339 France: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 340 Spain: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 341 Spain: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 342 Spain: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 343 Spain: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 344 Spain: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 345 Spain: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 346 Spain: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 347 Spain: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 348 UK: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 349 UK: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 350 UK: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 351 UK: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 352 UK: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 353 UK: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 354 UK: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 355 UK: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 356 Russia: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 357 Russia: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 358 Russia: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 359 Russia: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 360 Russia: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 361 Russia: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 362 Russia: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 363 Russia: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 364 Rest of Europe: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 365 Rest of Europe: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 366 Rest of Europe: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 367 Rest of Europe: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 368 Rest of Europe: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 369 Rest of Europe: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 370 Rest of Europe: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 371 Rest of Europe: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 372 Asia-Pacific: Key Macroindicators
Table 373 Asia-Pacific: Immunoassay Market, by Country, 2023-2030 (USD Million)
Table 374 Asia-Pacific: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 375 Asia-Pacific: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 376 Asia-Pacific: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 377 Asia-Pacific: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 378 Asia-Pacific: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 379 Asia-Pacific: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 380 Asia-Pacific: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 381 Asia-Pacific: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 382 Japan: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 383 Japan: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 384 Japan: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 385 Japan: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 386 Japan: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 387 Japan: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 388 Japan: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 389 Japan: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 390 China: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 391 China: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 392 China: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 393 China: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 394 China: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 395 China: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 396 China: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 397 China: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 398 India: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 399 India: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 400 India: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 401 India: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 402 India: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 403 India: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 404 India: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 405 India: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 406 Australia: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 407 Australia: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 408 Australia: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 409 Australia: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 410 Australia: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 411 Australia: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 412 Australia: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 413 Australia: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 414 South Korea: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 415 South Korea: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 416 South Korea: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 417 South Korea: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 418 South Korea: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 419 South Korea: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 420 South Korea: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 421 South Korea: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 422 Indonesia: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 423 Indonesia: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 424 Indonesia: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 425 Indonesia: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 426 Indonesia: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 427 Indonesia: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 428 Indonesia: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 429 Indonesia: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 430 Rest of Asia-Pacific: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 431 Rest of Asia-Pacific: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 432 Rest of Asia-Pacific: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 433 Rest of Asia-Pacific: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 434 Rest of Asia-Pacific: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 435 Rest of Asia-Pacific: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 436 Rest of Asia-Pacific: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 437 Rest of Asia-Pacific: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 438 Latin America: Key Macroindicators
Table 439 Latin America: Immunoassay Market, by Country, 2023-2030 (USD Million)
Table 440 Latin America: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 441 Latin America: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 442 Latin America: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 443 Latin America: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 444 Latin America: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 445 Latin America: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 446 Latin America: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 447 Latin America: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 448 Brazil: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 449 Brazil: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 450 Brazil: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 451 Brazil: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 452 Brazil: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 453 Brazil: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 454 Brazil: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 455 Brazil: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 456 Mexico: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 457 Mexico: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 458 Mexico: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 459 Mexico: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 460 Mexico: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 461 Mexico: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 462 Mexico: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 463 Mexico: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 464 Rest of Latin America: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 465 Rest of Latin America: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 466 Rest of Latin America: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 467 Rest of Latin America: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 468 Rest of Latin America: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 469 Rest of Latin America: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 470 Rest of Latin America: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 471 Rest of Latin America: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 472 Middle East & Africa: Immunoassay Market, by Product, 2023-2030 (USD Million)
Table 473 Middle East & Africa: Immunoassay Reagents & Kits Market, by Type, 2023-2030 (USD Million)
Table 474 Middle East & Africa: Immunoassay Analyzers Market, by Type, 2023-2030 (USD Million)
Table 475 Middle East & Africa: Immunoassay Analyzers Market, by Purchase Mode, 2023-2030 (USD Million)
Table 476 Middle East & Africa: Immunoassay Market, by Technology, 2023-2030 (USD Million)
Table 477 Middle East & Africa: Immunoassay Market, by Specimen, 2023-2030 (USD Million)
Table 478 Middle East & Africa: Immunoassay Market, by Application, 2023-2030 (USD Million)
Table 479 Middle East & Africa: Immunoassay Market, by End-user, 2023-2030 (USD Million)
Table 480 Overview of Key Strategies Deployed by Major Players in Immunoassay Market
Table 481 Immunoassay Market: Degree of Competition
Table 482 Immunoassay Market: Region Footprint
Table 483 Immunoassay Market: Product Footprint
Table 484 Immunoassay Market: Specimen Footprint
Table 485 Immunoassay Market: List of Key Startups/SME Players
Table 486 Immunoassay Market: Competitive Benchmarking of Startups/ SME Players, by Region
Table 487 Immunoassay Market: Product Launches/Approvals/Enhancements, January 2022-July 2025
Table 488 Immunoassay Market: Deals, January 2022-July 2025
Table 489 Abbott: Company Overview
Table 490 Abbott: Products Offered
Table 491 Abbott: Product Approvals, January 2022-June 2025
Table 492 Abbott: Deals, January 2022-June 2025
Table 493 Abbott: Expansions, January 2022-June 2025
Table 494 F. Hoffmann-La Roche Ltd.: Company Overview
Table 495 F. Hoffmann-La Roche Ltd.: Products Offered
Table 496 F. Hoffmann-La Roche Ltd.: Product Launches and Approvals, January 2022-June 2025
Table 497 F. Hoffmann-La Roche Ltd.: Deals, January 2022-June 2025
Table 498 F. Hoffmann-La Roche Ltd.: Expansions, January 2022-June 2025
Table 499 Siemens Healthineers AG: Company Overview
Table 500 Siemens Healthineers AG: Products Offered
Table 501 Siemens Healthineers AG: Product Launches and Approvals, January 2022-June 2025
Table 502 Siemens Healthineers AG: Deals, January 2022-June 2025
Table 503 Siemens Healthineers AG: Expansions, January 2022-June 2025
Table 504 Danaher: Company Overview
Table 505 Danaher: Products Offered
Table 506 Danaher: Product Launches and Approvals, January 2022-June 2025
Table 507 Danaher: Deals, January 2022-June 2025
Table 508 Danaher: Expansions, January 2022-June 2025
Table 509 Thermo Fisher Scientific Inc.: Company Overview
Table 510 Thermo Fisher Scientific Inc.: Products Offered
Table 511 Thermo Fisher Scientific Inc.: Product Approvals, January 2022-June 2025
Table 512 Thermo Fisher Scientific Inc.: Deals, January 2022-June 2025
Table 513 Revvity: Company Overview
Table 514 Revvity: Products Offered
Table 515 Revvity: Product Approvals, January 2022-June 2025
Table 516 Revvity: Other Developments, January 2022-June 2025
Table 517 Becton, Dickinson and Company (Bd): Company Overview
Table 518 Becton, Dickinson and Company (Bd): Products Offered
Table 519 Becton, Dickinson and Company (Bd): Expansions, January 2022-June 2025
Table 520 Diasorin S.P.A.: Company Overview
Table 521 Diasorin S.P.A.: Products Offered
Table 522 Diasorin S.P.A.: Product Launches and Approvals, January 2022-June 2025
Table 523 Diasorin S.P.A.: Deals, January 2022-June 2025
Table 524 Bio-Rad Laboratories, Inc.: Company Overview
Table 525 Bio-Rad Laboratories, Inc.: Products Offered
Table 526 Bio-Rad Laboratories, Inc.: Product Launches, January 2022-June 2025
Table 527 Bio-Rad Laboratories, Inc.: Deals, January 2022-June 2025
Table 528 Quidelortho Corporation: Company Overview
Table 529 Quidelortho Corporation: Products Offered
Table 530 Quidelortho Corporation: Product Approvals, January 2022-June 2025
Table 531 Quidelortho Corporation: Deals, January 2022-June 2025
Table 532 Quidelortho Corporation: Expansions, January 2022-June 2025
Table 533 Biomérieux: Company Overview
Table 534 Biomérieux: Products Offered
Table 535 Biomérieux: Product Launches and Approvals, January 2022-June 2025
Table 536 Biomérieux: Deals, January 2022-June 2025
Table 537 Qiagen: Company Overview
Table 538 Qiagen: Products Offered
Table 539 Qiagen: Deals, January 2022-June 2025
Table 540 Sysmex Corporation: Company Overview
Table 541 Sysmex Corporation: Products Offered
Table 542 Sysmex Corporation: Deals, January 2022-June 2025
Table 543 Sysmex Corporation: Expansions, January 2022-June 2025
Table 544 Agilent Technologies, Inc.: Company Overview
Table 545 Agilent Technologies, Inc.: Products Offered
Table 546 Agilent Technologies, Inc.: Product Launches and Approvals, January 2022-June 2025
Table 547 Agilent Technologies, Inc.: Deals, January 2022-June 2025
Table 548 Agilent Technologies, Inc.: Other Developments, January 2022-June 2025
Table 549 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Company Overview
Table 550 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Products Offered
Table 551 Merck KGaA: Company Overview
Table 552 Meridian Bioscience: Company Overview
Table 553 Bio-Techne: Company Overview
Table 554 Cellabs: Company Overview
Table 555 Abnova Corporation: Company Overview
Table 556 J. Mitra & Co. Pvt. Ltd.: Company Overview
Table 557 Tosoh Corporation (Tosoh Biosciences): Company Overview
Table 558 Cell Sciences: Company Overview
Table 559 Enzo Biochem Inc.: Company Overview
Table 560 Creative Diagnostics: Company Overview
Table 561 Boster Biological Technology: Company Overview
Table 562 Elabscience Bionovaton Inc.: Company Overview
Table 563 Wak-Chemie Medical GmbH: Company Overview
Table 564 Sera Care: Company Overview
Table 565 Epitope Diagnostics, Inc.: Company Overview
Table 566 Kamiya Biomedical Company: Company Overview
Table 567 Gyros Protein Technologies Ab: Company Overview
Table 568 Trivitron Healthcare: Company Overview
Table 569 Inbios International, Inc.: Company Overview
Table 570 Maccura Biotechnology Co. Ltd.: Company Overview

Figure 1 Immunoassay Market Segmentation & Regional Scope
Figure 2 Immunoassay Market: Years Considered
Figure 3 Immunoassay Market: Research Design
Figure 4 Immunoassay Market: Key Data from Secondary Sources
Figure 5 Immunoassay Market: Key Primary Sources
Figure 6 Immunoassay Market: Key Insights from Industry Experts
Figure 7 Breakdown of Primary Interviews: Supply- and Demand-Side Participants
Figure 8 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 9 Immunoassay Market: Company Revenue Estimation (Revenue Share Analysis)
Figure 10 Immunoassay Market: CAGR Projections (Supply-Side Analysis)
Figure 11 Immunoassay Market: Top-Down Approach
Figure 12 Immunoassay Market: Data Triangulation Methodology
Figure 13 Immunoassay Market, by Product, 2025 vs. 2030 (USD Billion)
Figure 14 Immunoassay Market, by Technology, 2025 vs. 2030 (USD Billion)
Figure 15 Immunoassay Market, by Specimen, 2025 vs. 2030 (USD Billion)
Figure 16 Immunoassay Market, by Application, 2025 vs. 2030 (USD Billion)
Figure 17 Immunoassay Market, by End-user, 2025 vs. 2030 (USD Billion)
Figure 18 Regional Snapshot of Immunoassay Market
Figure 19 Favorable Regulatory Scenario and High Prevalence of Infectious Diseases to Drive Market
Figure 20 US and Reagents & Kits Commanded Largest Share of North American Immunoassay Market in 2024
Figure 21 China to Witness Highest Growth Rate During Forecast Period
Figure 22 Asia-Pacific to Witness Highest CAGR During Study Period
Figure 23 Immunoassay Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Rate of Increase in Incidence of Diabetes Globally (In Million)
Figure 25 US: Regulatory Process for In-Virto Diagnostic Devices
Figure 26 Canada: Regulatory Process for In-Virto Diagnostic Devices
Figure 27 Japan: Regulatory Process for In-Virto Diagnostic Devices
Figure 28 India: Regulatory Process for In-Virto Diagnostic Devices
Figure 29 Mexico: Regulatory Process for In-Virto Diagnostic Devices
Figure 30 Brazil: Regulatory Process for In-Virto Diagnostic Devices
Figure 31 Top 10 Patent Owners/Applicants in Immunoassay Market, January 2015-December 2024
Figure 32 Immunoassay Market: Value Chain Analysis
Figure 33 Immunoassay Market: Supply Chain Analysis
Figure 34 Immunoassay Market: Ecosystem Analysis
Figure 35 Immunoassay Market: Porter's Five Forces Analysis
Figure 36 Influence of Key Stakeholders on Buying Process, by End-user
Figure 37 Key Buying Criteria for Top End-users
Figure 38 Immunoassay Market: Trends/Distruptions Impacting Customers’ Businesses
Figure 39 Immunoassay Market: Funding and Number of Deals, 2018-2025 (USD Million)
Figure 40 Market Potential of AI/Gen AI in Enhancing Immunoassay Diagnosis and Treatment Planning
Figure 41 North America: Immunoassay Market Snapshot
Figure 42 Asia-Pacific: Immunoassay Market Snapshot
Figure 43 Revenue Analysis of Key Players in Immunoassay Market (2020-2024)
Figure 44 Market Share Analysis of Key Players in Immunoassay Market (2024)
Figure 45 Immunoassay Market: Company Evaluation Matrix (Key Players), 2024
Figure 46 Immunoassay Market: Company Footprint
Figure 47 Immunoassay Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 48 EV/EBITDA of Key Vendors, 2025
Figure 49 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors, 2025
Figure 50 Immunoassay Market: Brand/Product Comparative Analysis
Figure 51 Abbott: Company Snapshot
Figure 52 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 53 Siemens Healthineers AG: Company Snapshot
Figure 54 Danaher: Company Snapshot
Figure 55 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 56 Revvity: Company Snapshot
Figure 57 Becton, Dickinson and Company (Bd): Company Snapshot
Figure 58 Diasorin S.P.A.: Company Snapshot
Figure 59 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 60 Quidelortho Corporation: Company Snapshot
Figure 61 Biomérieux: Company Snapshot
Figure 62 Qiagen: Company Snapshot
Figure 63 Sysmex Corporation: Company Snapshot
Figure 64 Agilent Technologies, Inc.: Company Snapshot
Figure 65 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Company Snapshot